Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-788-6 | CAS number: 110-65-6
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The skin sensitizing potential of 1,4 -Butynediol (B3D) has been examined in 3 well documented GLP and non-GLP OECD 406 guideline (or equivalent) in vivo studies (BG Chemie 1990, Jedrychowski, et. al. 1992, and Hüls AG 1985). In all three studies, B3D did not produce significant skin sensitization. These data are supported by results in human patch testing that, although showing significant skin reactions after challenge applications, failed to reliably demonstrate a sensitizing effect (Kligman, 1966 and GAF, undated).
Migrated from Short description of key information:
Not a skin sensitizer
Justification for classification or non-classification
1,4-Butynediol is classified as a skin sensitizer under Annex I of EU Directive 67/548/EEC and Annex VI of Regulation (EC) 1272/2008. However, this mandatory classification does not appear warranted based on the following two factors: (1) predominantly negative results of three OECD 406 Guideline, or equivalent, studies performed according to the Guinea Pig Maximisation protocol, one of which was performed under GLP conditions and which either showed no positive response or a response rate of <30%, and (2) the results of human patch testing which, although showing significant skin reactions after challenge applications, failed to reliably demonstrate a sensitizing effect.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
